RADIKAL THERAPEUTICS INC has a total of 26 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are TREAMID THERAPEUTICS GMBH, PULMAGEN THERAPEUTICS INFLAMMATION LTD and IVASHCHENKO ANDREY ALEXANDROVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Hungary | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Serbia | 1 | |
#11 | Slovenia | 1 |
# | Name | Total Patents |
---|---|---|
#1 | Salzman Andrew Lurie | 25 |
#2 | Jagtap Prakash | 18 |
#3 | Southan Garry John | 8 |
#4 | Prakash Jagtap | 1 |
#5 | Magdassi Shlomo | 1 |
#6 | Margulis-Goshen Katrin | 1 |
#7 | Andrew Lurie Salzman | 1 |
#8 | Southan Garry | 1 |
#9 | Garry John Southan | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016009341A1 | Thioredoxin mimetic prodrugs and uses thereof | |
US2016002171A1 | Substituted 1-pyrrolidinyloxy, 1-piperidinyloxy and 1-azepanyloxy compounds for treating diseases associated with oxidative stress or endothelial dysfunction | |
WO2013190497A2 | Compositions and methods for treatment of inflammatory diseases of the lung | |
WO2013005216A1 | Compositions and methods for treatment of renal ischemia-reperfusion injury | |
RS54889B1 | Multifunctional nitroxide derivatives and uses thereof | |
WO2012093383A1 | Compositions and methods for treatment of sepsis and related conditions | |
AU2011251622A1 | Lipoic acid and nitroxide derivatives and uses thereof |